HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolic acidosis in the critically ill: part 2. Causes and treatment.

Abstract
The correct identification of the cause, and ideally the individual acid, responsible for metabolic acidosis in the critically ill ensures rational management. In Part 2 of this review, we examine the elevated (corrected) anion gap acidoses (lactic, ketones, uraemic and toxin ingestion) and contrast them with nonelevated conditions (bicarbonate wasting, renal tubular acidoses and iatrogenic hyperchloraemia) using readily available base excess and anion gap techniques. The potentially erroneous interpretation of elevated lactate signifying cell ischaemia is highlighted. We provide diagnostic and therapeutic guidance when faced with a high anion gap acidosis, for example pyroglutamate, in the common clinical scenario 'I can't identify the acid--but I know it's there'. The evidence that metabolic acidosis affects outcomes and thus warrants correction is considered and we provide management guidance including extracorporeal removal and fomepizole therapy.
AuthorsC G Morris, J Low
JournalAnaesthesia (Anaesthesia) Vol. 63 Issue 4 Pg. 396-411 (Apr 2008) ISSN: 1365-2044 [Electronic] England
PMID18336491 (Publication Type: Journal Article, Review)
Topics
  • Acid-Base Equilibrium
  • Acidosis (diagnosis, etiology, therapy)
  • Acidosis, Lactic (etiology, therapy)
  • Acidosis, Renal Tubular (etiology, therapy)
  • Critical Illness
  • Humans
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: